The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial

BACKGROUND: Alzheimer’s disease (AD) is characterized not only by cognitive and functional decline, but also often by the presence of neuropsychiatric symptoms. Apathy, which can be defined as a lack of motivation, is one of the most prevalent neuropsychiatric symptoms in AD and typically leads to a...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Trials
Main Authors: Scherer, Roberta W., Drye, Lea, Mintzer, Jacobo, Lanctôt, Krista, Rosenberg, Paul, Herrmann, Nathan, Padala, Prasad, Brawman-Mintzer, Olga, Burke, William, Craft, Suzanne, Lerner, Alan J., Levey, Allan, Porsteinsson, Anton, van Dyck, Christopher H.
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2018
נושאים:
Study Protocol
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5774109/
https://ncbi.nlm.nih.gov/pubmed/29347996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-017-2406-5
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים